Albany Molecular Research Sees Unusually-High Trading Volume (AMRI)
Tuesday, October 20, 2015
Source: District of Columbia Progressive
Albany Molecular Research (NASDAQ:AMRI) saw an uptick in trading volume on Monday , Analyst Ratings.Net reports. 288,987 shares changed hands during trading, a decline of 19% from the previous session’s volume of 358,277 shares.The stock last traded at $17.77 and had previously closed at $17.70.
The stock’s 50 day moving average is $18.98 and its 200 day moving average is $19.64. The firm’s market capitalization is $580.39 million.
Albany Molecular Research (NASDAQ:AMRI) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.04. The business had revenue of $85.20 million for the quarter, compared to analysts’ expectations of $85 million. Equities analysts expect that Albany Molecular Research will post $0.90 earnings per share for the current year.